Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Sign up freePricing

Prism (General Partner) Limited investment portfolio

Prism (General Partner) Limited has made numerous investments in companies such as Mitorx Therapeutics, Spaceflux, and Pencil Biosciences within the DeepTech sector.

unknown
Portfolio
3
Team
0

Ownership Chain

Sign up free to see the Persons with Significant Control resolved from Companies House.

Sign up free

Portfolio (3)

CompanySectorSourceLast confirmed on
Mitorx Therapeutics Limited
MITORX THERAPEUTICS LIMITED develops novel mitochondrial-targeted small molecule therapeutics to modulate mitochondrial metabolism. Their lead program, Myo-004, is designed to achieve weight loss while preserving lean muscle mass, targeting obesity and other cardiometabolic diseases.
Healthcare & Life SciencesConfirmed2026-03-01
Pencil Biosciences Limited
PENCIL BIOSCIENCES LIMITED develops a proprietary, synthetic, modular, non-CRISPR gene-editing and modulation platform. This technology aims to provide new therapeutic options for patients with rare diseases, cancer, and genetic diseases, and has applications in infectious disease treatment, diagnostics, agriculture, and cell line engineering.
Healthcare & Life SciencesConfirmed2025-05-24

Sign up to see the full portfolio

+1 more company

Sign up

Shareholding changes (2)

Sign up free to see when this investor has bought or sold shares.

Sign up free

Articles (2)